6.1.2.1: D-alanine-(R)-lactate ligase
This is an abbreviated version!
For detailed information about D-alanine-(R)-lactate ligase, go to the full flat file.
Word Map on EC 6.1.2.1
-
6.1.2.1
-
vancomycin
-
glycopeptide
-
peptidoglycan
-
vancomycin-resistant
-
faecium
-
ligases
-
aureus
-
d-alanyl-d-alanine
-
glycopeptide-resistant
-
enterococcal
-
subsite
-
hydrogen-bonding
-
faecalis
-
teicoplanins
-
omega-loop
-
d-ala-d-lactate
-
penicillin
-
d-ala:d-ala
-
resort
-
vand-type
-
d-alanine:d-alanine
-
desulfitobacterium
-
amycolatopsis
-
hafniense
-
teicoplanin-resistant
-
mesenteroides
-
leuconostoc
-
d-ala2
-
synthesis
- 6.1.2.1
- vancomycin
- glycopeptide
- peptidoglycan
-
vancomycin-resistant
- faecium
- ligases
- aureus
- d-alanyl-d-alanine
-
glycopeptide-resistant
-
enterococcal
-
subsite
-
hydrogen-bonding
- faecalis
- teicoplanins
-
omega-loop
- d-ala-d-lactate
- penicillin
-
d-ala:d-ala
-
resort
-
vand-type
-
d-alanine:d-alanine
- desulfitobacterium
-
amycolatopsis
- hafniense
-
teicoplanin-resistant
- mesenteroides
-
leuconostoc
-
d-ala2
- synthesis
Reaction
Synonyms
D-Ala-D-Lac ligase, D-Ala:D-Lac ligase, D-alanine-D-lactate ligase, D-alanine:D-alanine (D-lactate) ligase (ADP), D-alanine:D-lactate ligase, D-alanyl-D-lactate ligase, depsipeptide ligase, VanA, VanB, VanD, VanD4, VanI, VRSA-9 Ddl
ECTree
Advanced search results
Engineering
Engineering on EC 6.1.2.1 - D-alanine-(R)-lactate ligase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
S150A
-
mutant of D-Ala-D-Ala ligase Ddl, mutant has gained depsipeptide ligase activity, i.e. formation of D-Ala-D-Lac, D-Ala-D-hydroxybutyrate, with dipeptide/depsipeptide partition ratios that mimic the pH behaviour of D-Ala-D-lactate ligase VanA. Mutant displays a clear pH-dependent partitioning between the preferred depsipeptide product at low pH and the dipeptide product at high pH
Y216F
-
mutant of D-Ala-D-Ala ligase Ddl, mutant has gained depsipeptide ligase activity, i.e. formation of D-Ala-D-Lac, D-Ala-D-hydroxybutyrate, with dipeptide/depsipeptide partition ratios that mimic the pH behaviour of D-Ala-D-lactate ligase VanA. Mutant displays a clear pH-dependent partitioning between the preferred depsipeptide product at low pH and the dipeptide product at high pH
F261Y
-
the mutant shows a complete loss of the ability to make D-alanyl-(R)-lactate
Q260K/A283E
S137A
-
site-directed mutagenesis, the mutant D-alanine-D-alanine ligase also shows formation of D-alanyl-D-lactate depsipeptide in contrast to the wild-type enzyme, EC 6.3.2.4, which is inactive with (R)-lactate
S137A/Y207F
-
site-directed mutagenesis, the mutant D-alanine-D-alanine ligase also shows formation of D-alanyl-D-lactate depsipeptide in contrast to the wild-type enzyme, EC 6.3.2.4, which is inactive with (R)-lactate
S137F/Y207F
-
site-directed mutagenesis, the mutant D-alanine-D-alanine ligase also shows formation of D-alanyl-D-lactate depsipeptide in contrast to the wild-type enzyme, EC 6.3.2.4, which is inactive with (R)-lactate
S137G/Y207F
-
site-directed mutagenesis, the mutant D-alanine-D-alanine ligase also shows formation of D-alanyl-D-lactate depsipeptide in contrast to the wild-type enzyme, EC 6.3.2.4, which is inactive with (R)-lactate
S137T/Y207F
-
site-directed mutagenesis, the mutant D-alanine-D-alanine ligase also shows formation of D-alanyl-D-lactate depsipeptide in contrast to the wild-type enzyme, EC 6.3.2.4, which is inactive with (R)-lactate
Y201F/Y207F
-
site-directed mutagenesis, the mutant D-alanine-D-alanine ligase also shows formation of D-alanyl-D-lactate depsipeptide in contrast to the wild-type enzyme, EC 6.3.2.4, which is inactive with (R)-lactate
Y207F
-
site-directed mutagenesis, the mutant D-alanine-D-alanine ligase also shows formation of D-alanyl-D-lactate depsipeptide in contrast to the wild-type enzyme, EC 6.3.2.4, which is inactive with (R)-lactate
additional information
-
the two amino acid substitutions result from point mutations at nucleotide positions 778 and 848, respectively. The mutant enzyme VRSA-9 synthesizes precursors ending in D-Ala-D-Lac (72%) and D-Ala-D-Ala (21%) in the absence of vancomycin. VRSA-9 Ddl shows a 200fold loss of activity and the importance of conformational changes in the dimer interface which can indirectly affect the topology of the active site
Q260K/A283E
-
the two amino acid substitutions result from point mutations at nucleotide positions 778 and 848, respectively. The mutant enzyme VRSA-9 synthesizes precursors ending in D-Ala-D-Lac (72%) and D-Ala-D-Ala (21%) in the absence of vancomycin. VRSA-9 Ddl shows a 200fold loss of activity and the importance of conformational changes in the dimer interface which can indirectly affect the topology of the active site
-
-
construction of several mutant strains, generating a Bacillus subtilis strain BP341A expressing a depsipeptide-containing (D-Ala-D-Lac) lipid II, phenotype, overview. Strains BP341A-E, that require expression of the VanB-type operon for growth, have mutations in the endogenous Ddl ligase
additional information
-
construction of several mutant strains, generating a Bacillus subtilis strain BP341A expressing a depsipeptide-containing (D-Ala-D-Lac) lipid II, phenotype, overview. Strains BP341A-E, that require expression of the VanB-type operon for growth, have mutations in the endogenous Ddl ligase
-
additional information
-
structure-based modification of D-alanine-D-alanine ligase from strain ATCC 43589 for depsipeptide synthesis, overview